Trial Profile
Open, Randomized, Parallel Group, Single Dose, Bioavailability Comparison of 3 Certolizumab Pegol Solution Formulations (Lyophilized, Liquid, Pre-filled Syringe Formulation) to Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Oct 2014
Price :
$35
*
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors UCB
- 31 Dec 2008 New trial record.